• Publications
  • Influence
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.
BACKGROUND Cardiovascular disease is common in older adults with end-stage renal disease who are undergoing regular dialysis, but little is known about the prevalence and extent of cardiovascularExpand
  • 2,517
  • 72
  • PDF
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.
Although renal osteodystrophy and vitamin D analogs may be related to survival in maintenance hemodialysis (MHD) patients, most studies have examined associations between baseline values and survivalExpand
  • 798
  • 23
A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
In 8 adolescents with end-stage renal disease (ESRD), basal PTH concentrations measured with a novel immunoradiometric assay (IRMA) (Scantibodies Laboratory, Inc.; S-IRMA) were invariably lower thanExpand
  • 261
  • 15
Suppression of iron-regulatory hepcidin by vitamin D.
The antibacterial protein hepcidin regulates the absorption, tissue distribution, and extracellular concentration of iron by suppressing ferroportin-mediated export of cellular iron. In CKD, elevatedExpand
  • 174
  • 15
  • PDF
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
Fibroblast growth factor 23 (FGF-23), dentin matrix protein 1 (DMP1), and matrix extracellular phosphoglycoprotein (MEPE) are skeletal proteins involved in the regulation of phosphate homeostasis andExpand
  • 206
  • 13
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
  • 2,282
  • 12
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Intermittent calcitriol therapy is commonly used to treat secondary hyperparathyroidism in patients undergoing regular dialysis, but there is little available information about the histologicExpand
  • 296
  • 11
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
BACKGROUND AND OBJECTIVES Hepcidin is a key regulator of iron homeostasis, but its study in the setting of chronic kidney disease (CKD) has been hampered by the lack of validated serum assays. Expand
  • 258
  • 11
  • PDF
Early skeletal and biochemical alterations in pediatric chronic kidney disease.
BACKGROUND AND OBJECTIVES The relationship between parathyroid hormone, fibroblast growth factor 23 (FGF-23), and indices of bone turnover and mineralization in children with early CKD is unknown;Expand
  • 103
  • 10
  • PDF
Hypovitaminosis D in chronic kidney disease.
BACKGROUND AND OBJECTIVES Recent studies show high prevalence of suboptimal 25-hydroxyvitamin D levels in chronic kidney disease patients. This study sought to test the hypothesis that the prevalenceExpand
  • 138
  • 9